For the Inventor, By the Inventor

Enter assignee name

Troy, NY, United States of America

Virogenetics Corporation

USPTO Granted Patents = 34

% Expired Patents = 2.9

EPO Patents = 1

Forward Citations = 989

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Enzo Paoletti (34 out of 64 patents)

James Tartaglia (17 out of 32 patents)

William I Cox (15 out of 20 patents)

4. Jill Taylor (12 out of 16 patents)

5. Steven E Pincus (11 out of 13 patents)

6. Russell Robert Gettig (10 out of 12 patents)

7. Keith J Limbach (7 out of 7 patents)

8. Charles De Taisne (5 out of 7 patents)

9. Marion E Perkus (5 out of 5 patents)

10. Michel Albert Riviere (4 out of 23 patents)

11. Gerard P Johnson (4 out of 4 patents)

12. Elizabeth K Norton (4 out of 4 patents)

13. Jean-Christophe Francis Audonnet (4 out of 4 patents)

14. Hector Martinez (2 out of 2 patents)

15. Louis Ross (2 out of 2 patents)

34 patents: Sort by Forward Citations

1. 6632438 - Recombinant poxvirus cytomegalovirus, compositions, and uses (2003-10-14),

2. 6596279 - Immunodeficiency recombinant poxvirus (2003-07-22),

3. 6537594 - Vaccina virus comprising cytokine and/or tumor associated antigen genes (2003-03-25),

4. 6267965 - Recombinant poxvirus—cytomegalovirus compositions and uses (2001-07-31),

5. 6265189 - Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen (2001-07-24),

6. 6130066 - Vectors having enhanced expression and methods of making and uses thereof (2000-10-10),

7. 6017542 - Nucleotide and amino acid sequences of canine herpesvirus GD and uses (2000-01-25),

8. 6004777 - Vectors having enhanced expression, and methods of making and uses (1999-12-21),

9. 5990091 - Vectors having enhanced expression, and methods of making and uses (1999-11-23),

10. 5989561 - Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) (1999-11-23),

11. 5891442 - Infectious bursal disease virus recombination poxvirus vaccine (1999-04-06),

12. 5863542 - Recombinant attenuated ALVAC canaryopox virus containing heterologous (1999-01-26),

13. 5858373 - Recombinant poxvirus-feline infectious peritionitis virus, compositions (1999-01-12),

14. 5843456 - Alvac poxvirus-rabies compositions and combination compositions and uses (1998-12-01),

15. 5833975 - Canarypox virus expressing cytokine and/or tumor-associated antigen DNA (1998-11-10),

Virogenetics Corporation is a leading biotechnology company specializing in virology and genetic research. With a team of expert scientists, we are dedicated to advancing the understanding of viruses and developing innovative solutions for the prevention and treatment of viral infections. Our cutting-edge research focuses on viral vectors, gene therapy, and viral diagnostics. Visit our website to learn more about our groundbreaking work.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

34 Patents

#3 in Troy, NY

#600 in New York

#9,985 in US

#19,578 in the World

Troy, NY, United States of America

Virogenetics Corporation

Forward Citations = 989

25 inventors:

Enzo Paoletti (34 out of 64 patents)

James Tartaglia (17 out of 32 patents)

William I Cox (15 out of 20 patents)

4. Jill Taylor (12 out of 16 patents)

5. Steven E Pincus (11 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…